DM
Dermapharm Holding SE
DMPHF · OTC
$47.69 +0.00% (+$0.00)
Market Cap 2.03B €
P/E Ratio 13.84x
Div. Yield 2.10%
ROE 22.38%
Bulios Fair Price
$48.87
2.5% upside
Current Price
$47.69
Undervalued Fair Value Overvalued
According to Bulios Fair Price, DMPHF is currently trading close to its fair value. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
88 /100
Cheap P/E 13.84x
P/FCF 10.60x
EV/EBITDA 8.31x
Growth
30 /100
Declining EPS growth 0.40%
Book val. growth 9.30%
Rev. growth 4.35%
Profitability
83 /100
Strong Gross margin 34.74%
FCF margin 16.21%
Net margin 12.41%
Quality
68 /100
Excellent ROIC 10.18%
Asset turnover 0.53x
ROE 22.38%
Debt
45 /100
Moderate Debt/Equity 2.18x
Net debt/EBITDA 2.69x
Current ratio 1.71x
Stability
75 /100
Stable Beta 0.85x
Profitable years 6
Rev. volatility 7.03%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about DMPHF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Hans-Georg Feldmeier
Employees
3,500
Headquarters
Grünwald
Upcoming events
12 NOV
Earnings
Upcoming earnings report